Dentistry News | Medical XPRT

Rubius Therapeutics to Present Trials in Progress Poster on the Phase 1 Clinical Trial of RTX-321 for HPV 16-Positive Cancers at the 2021 American Society of Clinical Oncology Annual Meeting

Rubius Therapeutics, Inc. (Nasdaq:RUBY), a clinical-stage biopharmaceutical company that is genetically engineering red blood cells to create an entirely new class of cellular medicines called Red Cell Therapeutics™, today announced that the Company will present a Trials in Progress poster presentation for its lead artificial antigen-presenting (aAPC) cell program, RTX-321, at the American ...

May 19, 2021

By Rubius Therapeutics, Inc.

Notitia Biotechnologies company announces expansion of study population for Covid-19 phase 2 study (COVGUT20) for NBT-NM108

After months of preparation, Notitia Biotechnologies Company (Notitia) announced that its COVID-19 Phase 2 study (COVGUT20) for NBT-NM108 has been given support by the Food and Drug Administration (FDA) to expand its study population to all symptomatic COVID-19 patients. "Previously, our trial focused on COVID-19 patients with type 2 diabetes and prediabetes. Now with this timely expansion to ...

Apr. 28, 2021

By Notitia Biotechnologies

Align technology’s invisalign brand is the official smile partner of U.S. SKI & Snowboard

Align Technology, Inc. (Nasdaq: ALGN), makers of the Invisalign® clear aligner system, today announced a partnership with U.S. Ski & Snowboard, making the Invisalign brand the Official Smile of U.S. Ski & Snowboard, the Olympic national governing body of ski and snowboard sports in the United States. The multi-year, worldwide sponsorship includes development of original Invisalign ...

Mar. 25, 2021

By Align Technology, Inc.

Lakhmir Chawla, MD, of Silver Creek Pharmaceuticals Joins ExThera Medical Board of Directors

Professor Lakhmir Chawla, MD, has joined the board of directors of ExThera Medical Corporation, a privately held medical technology company whose Seraph 100 Microbind Affinity Blood Filter is authorized in the United States to treat critically ill COVID-19 patients. Dr. Chawla also serves as the Chair of the Scientific Advisory Board at the company Dr. Chawla is an internationally renowned ...

Mar. 23, 2021

By ExThera Medical Corporation

Arbitrator Requires SDC Financial, Llc to Pay Align an Additional $45.5 Million for A Total Award of $99.7 Million

Continued Strong Growth and Increasing Momentum for Invisalign Clear Aligners and iTero Systems and Services Across Products and Customer Channels Worldwide, Reflects the Strength of Align’s Doctor-Directed Model and the Align Digital Platform $99.7 million award includes the $54.2 million paid to Align to date for the capital account SDC required to pay $45.5 million and additional ...

Mar. 15, 2021

By Align Technology, Inc.

Align Technology announces winner of 2020 Invisalign Ortho Summit Case Shoot-Out

Align Technology, Inc. (NASDAQ: ALGN) today announced the winner of the 2020 Invisalign Ortho Summit Case Shoot-out, one of the Company’s live case presentations during the virtual Summit. Dr. Keith Sellers of Charlotte, North Carolina received the greatest number of attendee votes for his Class II/Class III Invisalign case presentation. The Invisalign Ortho Summit Case Shoot-out program ...

Mar. 5, 2021

By Align Technology, Inc.

Asensus Surgical Announces FDA Clearance in General Surgery

Asensus Surgical, Inc. (formerly TransEnterix, Inc.) (NYSE American: TRXC) , a medical device company that is digitizing the interface between the surgeon and patient to pioneer a new era of Performance-Guided Surgery™, today announced the Company has received an additional FDA clearance for the Senhance Surgical System which allows for indication expansion in general surgery in the United ...

Mar. 3, 2021

By Asensus Surgical US, Inc.

Novaerus Defend 1050 cleared by FDA as 510(k) Class II Medical Device

Defend 1050 uses patented NanoStrike® technology to damage and inactivate airborne micro-organisms. Dublin, Ireland and Stamford, CT - Novaerus, a WellAir company that delivers clean air solutions to help prevent the spread of infectious outbreaks, announced today that the U.S. Food and Drug Administration (FDA) cleared the Novaerus Defend 1050 (NV 1050) as a 510(k) Class II Medical Device ...

Feb. 1, 2021

By WellAir

Carmat outlines commercial and development plan for its total artificial heart

Addressable market in the bridge-to-transplant indication of more than 2,000 patients a year in Europe Company prepares for commercial launch in Q2 2021, with initial focus on Germany and France Robust clinical plan to support adoption and sales development Virtual conference with Stéphane Piat today at 5 pm CET CARMAT (FR0010907956, ALCAR), the designer and developer of the ...

Jan. 6, 2021

By Carmat

Atmo exhibits at Australian Gastroenterology Week

Atmo Biosciences exhibited at Australian Gastroenterology Week Conference in Adelaide thanks to the generous support of C.R. Kennedy. CEO Mal Hebblewhite reported plenty of interest from gastroenterologists regarding the two clinical trials Atmo recently commenced with Professor Peter Gibson at Monash University. There was also lots of discussion about using the Atmo Gas Capsule as a research ...

Sep. 23, 2020

By Atmo Biosciences

Espoo Health Services chose Genano to protect patients and staff from viruses in the air

Espoo Health Services was well prepared for the expansion of the corona epidemic and reorganized its operations. One of the tasks was to change the Samaria health station in the center of Espoo, Finland, into an infection center focusing on the treatment of respiratory infections. In the next phase, another health station was prepared for similar use in case the first infection center's ...

Apr. 15, 2020

By Genano Solutions

ExThera’s Affinity Blood Filter Is Used to Treat COVID-19 Patients

Treatment of COVID-19 with ExThera’s Seraph®100 Microbind® Affinity Blood Filter (Seraph 100) has begun in hospitals in Germany and Italy. Seraph 100 treatments of COVID-19 are also expected to begin soon in France and the USA. Seraph 100 is the only ‘hemoperfusion device’ approved for the reduction of pathogens in blood. In recent EU clinical cases improved lung ...

Mar. 26, 2020

By ExThera Medical Corporation

AdjuCor enters BMBF supported research collaboration for developing 3D printable biomimetic polymers that mimic properties of the pericardium.

MUNICH, Germany – February 4th, 2020: In the future, novel polymers should make it possible to individually manufacture artificial elastic tissue replacements for pericardium, heart valves or blood vessels. In the PolyKARD project, biomimetic polymers are being developed that can imitate the mechanical properties of pericardial tissue. Using 3D printing and electrospinning, these ...

Feb. 4, 2020

By AdjuCor GmbH

Here`s What You Can`t Miss at CES 2020

CES® 2020 is the world’s largest and most influential tech event, where the entire technology ecosystem gathers to conduct business, launch products, build brands and partner to solve some of the world’s most challenging issues. More than 4,500 exhibitors will launch nearly 20,000 new transformative tech products to more than 170,000 attendees, encompassing 5G connectivity, ...

Jan. 2, 2020

By Consumer Technology Association

Some Health Care Professionals in Puerto Rico at Risk of Exposure to Waste Anesthetic Gases

Waste anesthetic gases (WAGs) are small amounts of volatile anesthetic gases that leak from a patient’s anesthetic breathing circuit into the air of operating rooms during the delivery of anesthesia. These gases may also be exhaled by patients recovering from anesthesia. Waste anesthetic gases include both nitrous oxide and halogenated anesthetics. The Occupational Safety and Health ...

Dec. 16, 2019

By Cochrane & Associates, LLC

Plastics Healthcare Market Watch Highlights Plastics Growing Role in Medicine

In a Plastics Market Watch report released today, Watching: Plastics’ Contribution to Healthcare, The Plastics Industry Association (PLASTICS) reported a growing demand for plastics in a number of healthcare sectors including pharmaceuticals, surgical equipment and tools, vision/dental/hearing, research labs and more. According to the report, medical equipment and supplies production ...

Sep. 30, 2019

By Plastics Industry Association (Plastics)

BioTrace Medical Announces Key Events Featuring Tempo Temporary Pacing Lead at TCT 2019

BioTrace Medical, Inc., the leader in innovative temporary pacing technology, today announced the company’s key activities at the 31st annual Transcatheter Cardiovascular Therapeutics (TCT) conference, which will take place September 25-29 in San Francisco. The company’s Tempo Temporary Pacing Lead will be featured in a breakfast symposium titled “Keeping the Rhythm with the ...

Sep. 19, 2019

By BioTrace Medical Inc

Clariant Adds Pharmaceutical Desiccant Packet Production Capability in Cuddalore, India

The Clariant Healthcare Packaging business unit is now producing desiccant packets at its plant in Cuddalore, Tamil Nadu, India. The addition expands the range of desiccant products immediately available to customers in the region and increases global capacity. The plant now manufactures both Continu-Strip® continuous-roll desiccant packets and individually cut desiccant packets in a full ...

Aug. 27, 2019

By Clariant International Ltd.

The Lancet: Nerve transfer surgery restores hand function and elbow extension in 13 young adults with complete paralysis

Nerve transfer surgery has enabled 13 young adults with complete paralysis to regain movement and function in their elbows and hands, according to the largest case series of this technique in people with tetraplegia (paralysis of both the upper and lower limbs), published in The Lancet. During the surgery, Australian surgeons attached functioning nerves above the spinal injury to paralysed ...

Jul. 31, 2019

By Siemens AG

$2.9 million in pipeline program dual training grants awarded

Minnesota employees and their employers will benefit from nearly $2.9 million in state grants to fund employment-based dual training for 664 current and new employees as part of the Minnesota PIPELINE Program. The PIPELINE Programs’ Dual Training Grants, which were included in Gov. Tim Walz’s budget, give dual trainees the opportunity to earn while they learn and help businesses meet ...

Jun. 28, 2019

By Design Ready Controls (DRC)